Plegridy Observational Program

NCT02230969 · clinicaltrials.gov ↗

COMPLETED

Status

1208

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Forms of Multiple Sclerosis

Interventions

DRUG: peginterferon beta-1a

Sponsor

Biogen